We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. Applications and prospects of cryo-EM in drug discovery

    Drug discovery is a crucial part of human healthcare and has dramatically benefited human lifespan and life quality in recent centuries, however, it...

    Kong-Fu Zhu, Chuang Yuan, ... Hua-Wei Zhang in Military Medical Research
    Article Open access 06 March 2023
  2. Modulation of neuroinflammation and oxidative stress by targeting GPR55 – new approaches in the treatment of psychiatric disorders

    Pharmacological treatment of psychiatric disorders remains challenging in clinical, pharmacological, and scientific practice. Even if many different...

    Matthias Apweiler, Soraya Wilke Saliba, ... Bernd L. Fiebich in Molecular Psychiatry
    Article Open access 25 May 2024
  3. Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis

    Drug resistance and poor treatment response are major obstacles to the effective treatment of acute myeloid leukemia (AML). A deeper understanding of...

    **n Liu, Shuxin Zhong, ... Chengwu Zeng in Experimental Hematology & Oncology
    Article Open access 17 May 2023
  4. Tumor Pre-Targeting System Using Streptavidin-Expressing Bacteria

    Purpose

    A major obstacle to targeted cancer therapy is identifying suitable targets that are specifically and abundantly expressed by solid tumors....

    Seong-Young Kwon, Sung-Hwan You, ... Jung-Joon Min in Molecular Imaging and Biology
    Article 30 May 2024
  5. Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4

    The combination of programmed cell death protein 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) antibodies has potential for enhancing...

    Jianyao Zeng, Yuan Fang, ... Qijun Qian in Oncogene
    Article Open access 28 May 2024
  6. Drug-tolerant persister cells in cancer: the cutting edges and future directions

    Drug-tolerant persister (DTP) cell populations were originally discovered in antibiotic-resistant bacterial biofilms. Similar populations with...

    Yi Pu, Lu Li, ... Shensi Shen in Nature Reviews Clinical Oncology
    Article 25 September 2023
  7. Microglia in neuroimmunopharmacology and drug addiction

    Drug addiction is a chronic and debilitating disease that is considered a global health problem. Various cell types in the brain are involved in the...

    Hongyuan Li, Linda R. Watkins, **aohui Wang in Molecular Psychiatry
    Article 02 February 2024
  8. PI3K/AKT/mTOR inhibitors as potential extracellular matrix modulators for targeting EMT subtype gastric tumors

    Targeting the extracellular matrix (ECM) is considered as a promising strategy in cancer therapeutics. This study was designed to identify the...

    Ponmathi Panneerpandian, Kumaresan Ganesan in Medical Oncology
    Article 19 March 2023
  9. Preventing incubation of drug craving to treat drug relapse: from bench to bedside

    In 1986, Gawin and Kleber reported a progressive increase in cue-induced drug craving in individuals with cocaine use disorders during prolonged...

    **aoxing Liu, Kai Yuan, ... Ying Han in Molecular Psychiatry
    Article 16 January 2023
  10. Targeting ATR in patients with cancer

    Pharmacological inhibition of the ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR; also known as FRAP-related protein...

    Natalie Y. L. Ngoi, Patrick G. Pilié, ... Timothy A. Yap in Nature Reviews Clinical Oncology
    Article 20 February 2024
  11. Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance

    The tumor microenvironment (TME) represents a milieu enabling cancer cells to develop malignant properties, while concerted interactions between...

    Changxu Wang, Qilai Long, ... Yu Sun in Oncogene
    Article Open access 06 October 2022
  12. Network-based drug repurposing for schizophrenia

    Despite recent progress, the challenges in drug discovery for schizophrenia persist. However, computational drug repurposing has gained popularity as...

    Trang T. T. Truong, Zoe S. J. Liu, ... Ken Walder in Neuropsychopharmacology
    Article Open access 06 February 2024
  13. BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma

    Recently, many new therapies have improved the outcomes of patients with relapsed and/or refractory multiple myeloma (RRMM). Nevertheless, recurrence...

    Jiamin Fang, Fuling Zhou in Annals of Hematology
    Article 13 September 2023
  14. Anesthetic drug discovery with computer-aided drug design and machine learning

    Computer-aided drug design (CADD) has emerged as a highly effective and indispensable tool for streamlining the drug discovery process, leading to...

    **anggen Liu, Zhe Xue, ... Jiancheng Lv in Anesthesiology and Perioperative Science
    Article Open access 15 January 2024
  15. Targeting efficacy and anticancer activity of polymeric nanoparticles of SN-38 on colon cancer cell lines

    Background

    Colorectal cancer is the third most prevailing cancer in the whole world. Chemotherapeutic agents which are used for treatment have severe...

    Shilpi Prasad, J. S. Dangi in Future Journal of Pharmaceutical Sciences
    Article Open access 08 February 2023
  16. Uptake of lipid core nanoparticles by fragments of tissues collected during cerebral tumor excision surgeries: hypotheses for use in drug targeting therapy

    Purpose

    Malignant cerebral tumors have poor prognosis and the blood–brain barrier is a major hindrance for most drugs to reach those tumors. Lipid...

    Edmundo Luís Rodrigues Pereira, Danielle Cristinne Azevedo Feio, ... Raul Cavalcante Maranhão in Journal of Neuro-Oncology
    Article 25 May 2022
  17. Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities

    Acute lymphoblastic leukemia (ALL) is a hematological malignancy characterized by aberrant proliferation and accumulation of lymphoid precursor cells...

    Betül Budak, Ezgi Yağmur Tükel, ... Yağmur Kiraz in Annals of Hematology
    Article Open access 05 June 2024
  18. Long–Term Outcome After Discontinuation of CGRP-Targeting Therapy for Migraine

    Purpose of review

    Calcitonin gene-related peptide (CGRP)-targeting agents are potential candidates for disease-modifying migraine drugs. However, most...

    Soohyun Cho, Byung–Kun Kim in Current Pain and Headache Reports
    Article 29 April 2024
  19. Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers

    Purpose

    Resistance to chemotherapy and radiotherapy is the primary cause of a poor prognosis in oncological patients. Researchers identified many...

    Dawid Dorna, Jarosław Paluszczak in Journal of Cancer Research and Clinical Oncology
    Article Open access 15 July 2023
  20. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies

    Despite recent advancements in the diagnosis and treatment of breast cancer (BC), patient outcomes in terms of survival, recurrence, and disease...

    Khubaib Ali, Muhammad Nabeel, ... Hamid Saeed in Medical Oncology
    Article 09 April 2024
Did you find what you were looking for? Share feedback.